TUMOR-NECROSIS-FACTOR-ALPHA IS CHEMOKINETIC FOR LYMPHOKINE-ACTIVATED KILLER-CELLS - REGULATION BY CYCLIC ADENOSINE-MONOPHOSPHATE

被引:30
作者
MAGHAZACHI, AA
机构
[1] Molecular Immunology Section, Biotechnology Research Inst., Nat. Research Council Canada, Montreal, Que. H4P 2R2
关键词
CHEMOTAXIS; CHEMOKINESIS; CHOLERA TOXIN; TGF-BETA-1;
D O I
10.1002/jlb.49.3.302
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The ability of tumor necrosis factor-alpha (TNF-alpha) to attract lymphokine-activated killer (LAK) cells in vitro was examined. Utilizing modified Boyden chambers (BC), it was observed that TNF-alpha is not chemoattractant for LAK cells. On the other hand, TNF-alpha attracted both fresh and concanavalin A-activated T cells. However, when TNF-alpha was incubated in the upper compartments of BC and in the presence of LAK cells, it enhanced the random movement of these cells across the polycarbonate membranes. The effect of TNF-alpha was inhibited by incorporating anti-TNF-alpha antibody, or a high concentration (10 ng) of TFG-beta-1. The activity of TGF-beta-1 was reversed by anti-TGF-beta-1 antibody. Cholera toxin (CT), which is known to activate the endogenous level of cyclic adenosine monophosphate (cAMP) also inhibited TNF-alpha-induced LAK cell chemokinesis. The effect of CT was mimicked by the cAMP analog dibutyryl cAMP or by the phosphodiesterase inhibitors isobutyl methylxanthine or aminophylline. Measurement of the intracellular level of cAMP showed that cells incubated for 1, 2, or 4 hr with TNF-alpha have a lower level of cAMP, whereas those incubated with a high concentration of TGF-beta-1 produced significantly higher levels of this messenger. cAMP level was also increased in cells incubated with TGF-beta-1 plus TNF-alpha. This level was reduced to the background when anti-TGF-beta-1 antibody was added to the cultures. These results suggest that cAMP negatively regulates LAK cell chemokinesis.
引用
收藏
页码:302 / 308
页数:7
相关论文
共 31 条
[21]   INVIVO NEUTROPHIL EMIGRATION IN RESPONSE TO INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-ALPHA [J].
MASON, MJ ;
VANEPPS, DE .
JOURNAL OF LEUKOCYTE BIOLOGY, 1989, 45 (01) :62-68
[22]  
MING WJ, 1987, J IMMUNOL, V138, P1469
[23]  
PILARO AM, 1989, NATURAL KILLER CELLS, P84
[24]  
RATNER S, 1988, CANCER RES, V48, P3374
[25]  
RODOLFO M, 1989, CANCER IMMUNOL IMMUN, V28, P136
[26]   IMMUNOTHERAPY OF CANCER USING INTERLEUKIN-2 - CURRENT STATUS AND FUTURE-PROSPECTS [J].
ROSENBERG, SA .
IMMUNOLOGY TODAY, 1988, 9 (02) :58-62
[27]  
SPANGRUDE GJ, 1984, J IMMUNOL, V132, P354
[28]   SIGNAL TRANSDUCTION BY GUANINE-NUCLEOTIDE BINDING-PROTEINS [J].
SPIEGEL, AM .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1987, 49 (01) :1-16
[29]  
STEEN PD, 1989, J IMMUNOL, V143, P4324
[30]   MECHANISMS OF TUMOR NECROSIS FACTOR ALPHA-INDUCED LYMPHOPENIA, NEUTROPENIA, AND BIPHASIC NEUTROPHILIA - A STUDY OF LYMPHOCYTE RECIRCULATION AND HEMATOLOGIC INTERACTIONS OF TNF-ALPHA WITH ENDOGENOUS MEDIATORS OF LEUKOCYTE TRAFFICKING [J].
ULICH, TR ;
DELCASTILLO, J ;
NI, RX ;
BIKHAZI, N ;
CALVIN, L .
JOURNAL OF LEUKOCYTE BIOLOGY, 1989, 45 (02) :155-167